Advancing Strategies & CMC for mRNA- Based Therapeutic Development

Time: 9:30 am
day: Day One


  • How to optimise mRNA design to promote CD4 T cells immune response for mRNA therapeutics
  • Accelerating novel purification platforms for standardising production of mRNA- based therapeutics
  • Implementation of a scalable and flexible mRNA manufacturing platform and delivery supporting the Sanofi internal portfolio